- Home
- IPHA vs GENC Comparison
IPHA vs GENC Comparison
Compare IPHA & GENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IPHA | GENC |
|---|---|---|
| Founded | 1999 | N/A |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Construction/Ag Equipment/Trucks |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 174.2M | 205.4M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | IPHA | GENC |
|---|---|---|
| Price | $1.70 | $13.91 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $5.00 | ★ $16.00 |
| AVG Volume (30 Days) | 26.6K | ★ 29.7K |
| Earning Date | 09-17-2025 | 12-09-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 7.92 |
| EPS | N/A | ★ 1.07 |
| Revenue | $14,839,695.00 | ★ $115,437,000.00 |
| Revenue This Year | $22.29 | N/A |
| Revenue Next Year | $43.90 | N/A |
| P/E Ratio | ★ N/A | $13.09 |
| Revenue Growth | N/A | ★ 2.01 |
| 52 Week Low | $1.63 | $10.80 |
| 52 Week High | $2.63 | $17.40 |
Technical Indicators
Market Signals| Indicator | IPHA | GENC |
|---|---|---|
| Relative Strength Index (RSI) | 46.43 | 63.13 |
| Support Level | $1.72 | $13.50 |
| Resistance Level | $1.86 | $14.19 |
| Average True Range (ATR) | 0.08 | 0.38 |
| MACD | 0.01 | 0.11 |
| Stochastic Oscillator | 39.39 | 88.20 |
Price Performance
Historical ComparisonAbout IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About GENC Gencor Industries Inc.
Gencor Industries Inc and its subsidiaries is a manufacturer of heavy machinery used in the production of highway construction materials and environmental control equipment. The Company has one reporting segment, equipment for the highway construction industry. The firm's principal products include asphalt plants, combustion systems, hot mix asphalt plants, fluid heat transfer systems, and asphalt pavers.